Letters of Intent, October 1. The Patient-Centered Outcomes Research Institute (PCORI) will make grants to study alternative features of healthcare systems that have the greatest potential for sustained impact and replication. Priority research areas include patients’ access to care, professional decision-making on the basis of patients’ personal values, and the efficiency of healthcare delivery. Populations of interest include residents of rural areas, racial and ethnic minority groups, low-income groups, and individuals with low health literacy. Any public or private research organization is eligible to apply for awards of up to $3 million for a three-year project.
Letters of Intent are due Tuesday, October 1, 2019, by 5:00 p.m. ET.
Those selected to submit a full application will be notified by Tuesday, October 29, 2019.
Full applications will be due Tuesday, January 14, 2020, by 5:00 p.m. ET.
Click here for further details.
Mid-career nurse scientists are invited to participate in the research study “Barriers and facilitators to success at mid-career for nurse scientists” being conducted by mid-career nurse scientists from the Southern Nursing Research Society.
Challenges for mid-career nurse scientists is a national concern. The goal of this study is to learn more about what those challenges are and how nursing organizations can address those challenges and facilitate support. You may participate in this study as a self-identified mid-career.
If you are interested in participating, please copy/paste the link or follow this link to the survey: http://ucf.qualtrics.com/jfe/form/SV_eeQnji3ldHn210h
Click here for information on National Institutes of Health inclusion policies for researching involving Human Subjects.
Navigate to learn more about NIH policies on the inclusion of women and minorities and the inclusion of individuals across the lifespan.
There is information on how the policies have been implemented in applications, peer review, and progress reports, and tables with policy notices and resources.
The HEAL Initiative is a trans-NIH effort launched in April 2018 to advance national priorities in addressing the opioid crisis through science. It has a focus on two primary areas – improving treatments for opioid misuse and addiction, and enhancing strategies for pain management.
Continue reading “Helping to End Addiction Long-term (HEAL) Initiative”
The National Institutes of Health has released its first Strategic Plan for Data Science that provides a roadmap for modernizing the NIH-funded biomedical data science ecosystem. Over the course of the next year, NIH will begin implementing its strategy, with some elements of the plan already underway. NIH will continue to seek community input during the implementation phase.
Accessible, well-organized, secure, and efficiently operated data resources are critical to modern scientific inquiry. By maximizing the value of data generated through NIH-funded efforts, the pace of biomedical discoveries and medical breakthroughs for better health outcomes can be substantially accelerated. To keep pace with rapid changes in biomedical data science, NIH will work to address the:
- findability, interconnectivity, and interoperability of NIH-funded biomedical data sets and resources
- integration of existing data management tools and development of new ones
- universalizing innovative algorithms and tools created by academic scientists into enterprise-ready resources that meet industry standards of ease of use and efficiency of operation
- growing costs of data management
Further information can be found here.
The National Institutes of Health has provided a number of case studies to help to identify whether a proposed study would be considered a clinical trial. Be aware that these case studies and related guidance will evolve over the upcoming year.
The simplified case studies apply the following four questions to determine whether NIH would consider the research study to be a clinical trial:
- Does the study involve human participants?
- Are the participants prospectively assigned to an intervention?
- Is the study designed to evaluate the effect of the intervention on the participants?
- Is the effect being evaluated a health-related biomedical or behavioral outcome ?
If the answer to all four questions is “yes,” then the clinical study would be considered a clinical trial according to the NIH definition.
Note that studies that involve secondary research with biological specimens or health information are not clinical trials.
Click here to review the case studies.
Mary Beth Happ, PhD, RN, FAAN, FGSA will present the third 2017 NINR Director’s Lecture on September 20 at the NIH Campus in Bethseda, Maryland. In her presentation, “Giving Voice to the Voiceless: Improving Communication with Critically Ill Patients,” Dr. Happ will describe her program of research which addresses family bedside presence during critical illness, end-of-life care and treatment decision making in the ICU, and patient and family outcomes in acute-critical illness.
This event is free and open to the public. It will be available on YouTube a few weeks following the lecture. You can learn more here.
In this fourth installment of our series highlighting recent research from our Doctor of Nursing Practice (DNP) program, we look at Evan M. McEwing’s inquiry into the delivery of culturally competent care to the Lesbian, Gay, Bisexual, and Transgender population.
Continue reading “DNP Research Spotlight #4: Delivering Culturally Competent Care to the LGBT Population”
The 28th International Nursing Research Congress recently took place in Dublin, Ireland, with several representatives from the University of Massachusetts Amherst College of Nursing in attendance.
Continue reading “2017 Sigma Theta Tau International Nursing Research Congress”
In this third installment of our series highlighting recent research from our Doctor of Nursing Practice (DNP) program, we look at Terri Morris’s investigation into education and mindfulness in the treatment of substance use disorder.
Continue reading “DNP Research Spotlight #3: Education and Mindfulness in the Treatment of Substance Use Disorder”